Suppr超能文献

他达拉非与氟西汀治疗早泄:一项前瞻性、随机、双盲、安慰剂对照研究。

Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study.

作者信息

Mattos Rogerio M, Marmo Lucon Antonio, Srougi Miguel

机构信息

Universidade de São Paulo, Institute of Urology, São Paulo, Brazil.

出版信息

Urol Int. 2008;80(2):162-5. doi: 10.1159/000112607. Epub 2008 Mar 19.

Abstract

INTRODUCTION

Premature ejaculation (PE) is a common male sexual disorder. An ideal, reliable and effective treatment is desired by many men and couples affected by this condition.

AIM

Evaluate if the association of a phosphodiesterase-5 inhibitor, tadalafil, and a selective serotonin reuptake inhibitor, fluoxetine, can prolong the intravaginal ejaculatory latency time (IELT) in men with lifelong premature ejaculation.

METHODS

Sixty patients with lifelong premature ejaculation and without erectile dysfunction (ED) with IELT less than 90 s were enrolled in the protocol and randomized into 4 groups to use a combination of medications: (1) tadalafil 20 mg plus fluoxetine 90 mg, (2) fluoxetine 90 mg plus placebo, (3) tadalafil 20 mg plus placebo, and (4) two different placebo capsules (control). Before starting the medications, each man timed his IELT with a stopwatch, and likewise during the treatment period. Fluoxetine 90 mg or placebo was taken once a week plus tadalafil 20 mg or placebo within a 36-hour frame of intended sexual intercourse with a steady partner. Patients were prospectively followed for 12 weeks. One-way ANOVA was used for statistical comparisons of IELT results in each group.

RESULTS

Mean IELT before starting treatment was 51.3 +/- 23 s. With one-way ANOVA, a statistically significant difference in post-treatment IELT was seen with combination treatment compared to placebo (p < 0.001). There were increases in IELT from baseline in patients using fluoxetine plus tadalafil (49.57 +/- 25.87 to 336.13 +/- 224.77) (p < 0.001), fluoxetine (56.55 +/- 18.55 to 233.62 +/- 105.08) (p < 0.001) and tadalafil (49.26 +/- 19.43 to 186.53 +/- 159.05) (p = 0.001). The increases in each group were statistically significant compared to the placebo (49.86 +/- 19.43 to 67.82 +/- 46.18) (p = 0.042).

CONCLUSION

Fluoxetine plus tadalafil significantly increased the IELT from baseline in men with lifelong premature ejaculation when compared to placebo, tadalafil or fluoxetine.

摘要

引言

早泄(PE)是一种常见的男性性功能障碍。许多受此疾病影响的男性及其伴侣都渴望获得一种理想、可靠且有效的治疗方法。

目的

评估磷酸二酯酶5抑制剂他达拉非与选择性5-羟色胺再摄取抑制剂氟西汀联合使用,能否延长终生早泄男性的阴道内射精潜伏期(IELT)。

方法

60例终生早泄且无勃起功能障碍(ED)、IELT小于90秒的患者纳入本方案,并随机分为4组使用联合药物:(1)他达拉非20毫克加氟西汀90毫克;(2)氟西汀90毫克加安慰剂;(3)他达拉非20毫克加安慰剂;(4)两种不同的安慰剂胶囊(对照组)。在开始用药前,每位男性用秒表记录其IELT,治疗期间同样如此。在与固定性伴侣进行有计划的性交的36小时内,每周服用一次氟西汀90毫克或安慰剂,同时服用他达拉非20毫克或安慰剂。对患者进行前瞻性随访12周。采用单因素方差分析对每组的IELT结果进行统计学比较。

结果

开始治疗前的平均IELT为51.3 +/- 23秒。通过单因素方差分析,与安慰剂相比,联合治疗后IELT有统计学显著差异(p < 0.001)。使用氟西汀加他达拉非的患者IELT从基线水平增加(49.57 +/- 25.87至336.13 +/- 224.77)(p < 0.001),使用氟西汀的患者(56.55 +/- 18.55至233.62 +/- 105.08)(p < 0.001),使用他达拉非的患者(49.26 +/- 19.43至186.53 +/- 159.05)(p = 0.001)。与安慰剂组(49.86 +/- 19.43至67.82 +/- 46.18)(p = 0.042)相比,每组的增加均具有统计学显著性。

结论

与安慰剂、他达拉非或氟西汀相比,氟西汀加他达拉非可显著增加终生早泄男性的基线IELT。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验